ProciseDx™ Announced CE mark for its Procise CRP assay (C reaction protein), the first of its family of gastrointestinal markers. The in vitro diagnostic company focuses on a wide variety of rapid diagnostic tests for clinical diagnostic testing.
The announcement of the CE mark for the Procise CRP assay develops the strategy of ProciseDx™in developing 2 to 5-minute point-of-care tests that deliver rapid results with ease of use. The tests utilize finger prink blood or stool samples in order to quantify C reaction protein levels.
Peter Weslake, President of ProciseDx™, said "We are very excited to have the opportunity to build a diagnostics company with revolutionary and disruptive technology. We are launching our platform and gastrointestinal assay portfolio in Europe later this year".